PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·
K-STREET TRACKER

FOLLOW THE MONEY INTO THE SWAMP

Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.

Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies

💸 Top Spending Clients

🎯 Top Lobbied Tickers

#TickerFilingsTotal $
1META
Meta Platforms Inc.
129$50.2M
2PFE
Pfizer Inc.
87$48.6M
3GM
General Motors Company
103$48.4M
4V
Visa Inc.
46$37.7M
5AMZN
Amazon.com Inc.
80$35.3M
6LMT
Lockheed Martin Corporation
88$29.4M
7FDX
FedEx Corporation
82$28.3M
8LLY
Eli Lilly and Company
83$28.1M
9AMGN
Amgen Inc.
95$28.0M
10MRK
Merck & Co. Inc.
92$27.5M
11AAPL
Apple Inc.
64$26.8M
12GOOGL
Alphabet Inc. Class A
123$26.6M
13MO164$26.2M
14SO
Southern Company
108$26.1M
15UNH
UnitedHealth Group Inc.
67$23.9M
16VZ
Verizon Communications Inc.
116$23.8M
17TMUS159$22.7M
18CHTR137$22.6M
19GD
General Dynamics Corporation
127$22.5M
20T
AT&T Inc.
134$21.6M
21ORCL
Oracle Corporation
132$20.6M
22CMCSA
Comcast Corporation
141$20.4M
23CI
The Cigna Group
64$19.9M
24OXY
Occidental Petroleum Corporation
36$19.9M
25MSFT
Microsoft Corporation
122$19.2M

🆕 Filtered Filings · MADRIGAL PHARMACEUTICALS INC.

clear filters
DateTickerClientRegistrantAmountIssue
2026-04-24MDGLMADRIGAL PHARMACEUTICALS INC.MADRIGAL PHARMACEUTICALS, INC.$380KIssues related to CMMI drug pricing; 340B drug pricing Most Favored Nation drug pricing; Issues related to CMMI drug pricing
2026-04-20MDGLMADRIGAL PHARMACEUTICALS INC.CROSSROADS STRATEGIES, LLC$50KIssues related to drug pricing; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order. Issues related to CMMI Drug Pricing Demonstration Programs.
2026-04-18MDGLMADRIGAL PHARMACEUTICALS INC.CAPITOL COUNSEL LLC$60KFDA and regulatory issues related to the biopharmaceutical industry. FDA and regulatory issues related to the biopharmaceutical industry. FDA and regulatory issues related to the biopharmaceutical industry, including CMMI Drug Pricing Models.
2026-04-16MDGLMADRIGAL PHARMACEUTICALS INC.BALLARD PARTNERS$120KAdvocacy related to prescription drug access and pricing.
2026-02-18MDGLMADRIGAL PHARMACEUTICALS INC.CAPITOL COUNSEL LLC$0FDA and regulatory issues related to the biopharmaceutical industry. FDA and regulatory issues related to the biopharmaceutical industry. FDA and regulatory issues related to the biopharmaceutical industry.
2026-01-22MDGLMADRIGAL PHARMACEUTICALS INC.MADRIGAL PHARMACEUTICALS, INC.$280KIssues related to CMMI drug pricing Most Favored Nation drug pricing; Issues related to CMMI drug pricing
2026-01-20MDGLMADRIGAL PHARMACEUTICALS INC.CROSSROADS STRATEGIES, LLC$50KIssues related to drug pricing; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order. Issues related to CMMI Drug Pricing Demonstration Programs.
2026-01-14MDGLMADRIGAL PHARMACEUTICALS INC.BALLARD PARTNERS$80K
2026-01-14MDGLMADRIGAL PHARMACEUTICALS INC.BALLARD PARTNERS$60K
2025-12-09MDGLMADRIGAL PHARMACEUTICALS INC.BALLARD PARTNERS$0Advocacy related to prescription drug access and pricing.
2025-12-04MDGLMADRIGAL PHARMACEUTICALS INC.MADRIGAL PHARMACEUTICALS, INC.$30KMost Favored Nation drug pricing
2025-10-19MDGLMADRIGAL PHARMACEUTICALS INC.CROSSROADS STRATEGIES, LLC$20KIssues related to drug pricing.
2025-10-07MDGLMADRIGAL PHARMACEUTICALS INC.MADRIGAL PHARMACEUTICALS, INC.$0FDA and regulatory issues related to the biopharmaceutical industry FDA and regulatory issues related to the biopharmaceutical industry FDA and regulatory issues related to the biopharmaceutical industry FDA and regulatory issues related to the biopharmaceutical industry FDA and regulatory issues related to the biopharmaceutical industry FDA and regulatory issues related to the biopharmaceutical industry FDA and regulatory issues related to the biopharmaceutical industry FDA and regulatory issues related to the biopharmaceutical industry FDA and regulatory issues related to the biopharmaceutical industry
2025-10-06MDGLMADRIGAL PHARMACEUTICALS INC.CROSSROADS STRATEGIES, LLC$0Issues related to drug pricing.